History of growth hormone in the treatment of idiopathic short stature

doi:10.19538/j.ek2023110607

Chinese Journal of Practical Pediatrics ›› 2023, Vol. 38 ›› Issue (11): 838-842.DOI: 10.19538/j.ek2023110607

Previous Articles Next Articles

History of growth hormone in the treatment of idiopathic short stature

Department of Endocrinology，Genetics and Metabolism，Fuzhou Children's Hospital，Fujian Medical University，Fuzhou 350000，China

Online:2023-11-06 Published:2023-11-02

生长激素治疗儿童特发性矮身材的研究进展

福建医科大学附属福州儿童医院内分泌遗传代谢科，福建福州 350000

通讯作者: 陈瑞敏，电子信箱：chenrm321@sina.com

Abstract

Abstract: Idiopathic short stature （ISS） is a general term of a group of short stature diseases of unknown etiology，The recognition to ISS can be traced back to the 1970s. Growth hormone （GH） has been approved by countries such as the United States，Belgium，Sweden，and China to be used used to improve the height of children with ISS. In this article，the history of recognition and treatment of GHin ISS is reviewed，in order to provide reference for clinical work.

Key words: idiopathic short stature, growth hormone, treatm-ent

摘要： 特发性矮身材（idiopathic short stature，ISS）是一组病因未明的矮身材疾病的总称。人们对ISS的认识最早可追溯至20世纪70年代。生长激素（growth hormone，GH）已被美国、比利时、瑞典、中国等国家批准用于改善ISS患儿身高。该文回顾了对ISS的认识过程及介绍GH治疗ISS的历史进程、以期为临床工作提供参考。

关键词: 特发性矮身材, 生长激素, 治疗

CHEN Rui-min, AI Zhuan-zhuan, CAI Bin-bin. History of growth hormone in the treatment of idiopathic short stature[J]. Chinese Journal of Practical Pediatrics, 2023, 38(11): 838-842.

陈瑞敏, 艾转转, 蔡彬彬. 生长激素治疗儿童特发性矮身材的研究进展[J]. 中国实用儿科杂志, 2023, 38(11): 838-842.

[1]	The Subspecialty Group of Endocrinology, Hereditary and Metabolic Diseases, the Society of Pediatrics, Chinese Medical Association, Adolescent Health and Medical Professional Committee, Chinese Medical Doctor Association, Futang Research Center of Pediatric Development, et al. Chinese expert consensus on the diagnosis and treatment of children with idiopathic short stature [J]. Chinese Journal of Practical Pediatrics, 2023, 38(11): 801-813.
[2]	YING Yan-qin, LIANG Yan. Advances in the genetics of idiopathic short stature in children [J]. Chinese Journal of Practical Pediatrics, 2023, 38(11): 818-822.
[3]	ZHU Gao-Hui, ZHU Min. Primary growth disorders related to growth plate in children [J]. Chinese Journal of Practical Pediatrics, 2023, 38(11): 823-828.
[4]	WU Wei，LUO Xiao-ping. Interpretation of Expert Consensus on the Diagnosis and Management of Growth Hormone Deficiency during the Transition Period [J]. CJPP, 2021, 36(8): 565-569.
[5]	XI Li， LUO Fei-hong. A hormonal approach to the evaluation of short stature [J]. CJPP, 2021, 36(8): 581-585.
[6]	CHENG Xin-ran，LENG Jie. GH-IGF-I axis signaling pathway and paracrine signaling pathways in the pathogenesis of growth disorder [J]. CJPP, 2021, 36(8): 592-597.
[7]	QIN Miao，GONG Chun-xiu. Growth hormone deficiency and nonalcoholic fatty liver disease [J]. CJPP, 2021, 36(8): 597-602.
[8]	WEI Hai-yan. Benefits and risks of growth hormone therapy based on evidence-based medicine [J]. CJPP, 2021, 36(8): 607-612.
[9]	WANG Chun-lin*，FU Jun-fen，LIANG Li. Advances in the study of drugs to improve growth of children with short stature [J]. CJPP, 2020, 35(6): 460-464.
[10]	ZHANG Ying，CHEN Rui-min，YANG Xiao-hong，et al. Clinical analysis of the recombinant human growth hormone combined with letrozole in the treatment of short pubertal boys [J]. CJPP, 2019, 34(9): 775-779.
[11]	LI Hui. Short stature and standardized use of growth hormone [J]. CJPP, 2019, 34(10): 815-818.
[12]	SU Zhe，DU Min-lian，MA Hua-mei，et al. Height velocity targets for the first year in response to recombinant human growth hormone（rhGH） treatment in pre-pubertal Growth Hormone Deficiency（GHD） children [J]. CJPP, 2017, 32(12): 929-932.
[13]	WANG Chun-lin, LIANG Li.. Diagnostic strategies in familial growth hormone deficiency. [J]. Acta Metallurgica Sinica, 2014, 29(8): 583-585.
[14]	LV Sheng，DONG Wen-ke，WANG Wei，DONG Zhi-ya，NI Ji-hong，CHEN Feng-sheng，WANG De-fen. The clinical value of different methods of predicting adult height applied to patients with idiopathic short stature. [J]. , 2012, 27(11): 860-862.
[15]	LIU Ying-ke，ZHANG Zhi-xin，ZHAO Qiu-ling，SU Hui-min，ZHANG Qiong. . Clinical observation on glucose and lipid metabolism in Turner syndrome children with growth hormone treatment.　　 [J]. , 2011, 26(05): 373-.

History of growth hormone in the treatment of idiopathic short stature

生长激素治疗儿童特发性矮身材的研究进展

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics